KH Feelux Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 14, 2023 at 04:01 am EDT
Share
KH Feelux Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was KRW 398.82 million compared to KRW 554.35 million a year ago. Net income was KRW 7,084.21 million compared to net loss of KRW 72,227.66 million a year ago. Basic earnings per share from continuing operations was KRW 615 compared to basic loss per share from continuing operations of KRW 7,110.0001 a year ago. Diluted earnings per share from continuing operations was KRW 390 compared to diluted loss per share from continuing operations of KRW 7,110.0001 a year ago. Basic earnings per share was KRW 615 compared to basic loss per share of KRW 7,110.0001 a year ago. Diluted earnings per share was KRW 390.
For the six months, sales was KRW 743.48 million compared to KRW 1,010.45 million a year ago. Net income was KRW 11,557.28 million compared to net loss of KRW 13,509.96 million a year ago. Basic earnings per share from continuing operations was KRW 930 compared to basic loss per share from continuing operations of KRW 1,380 a year ago. Diluted earnings per share from continuing operations was KRW 630 compared to diluted loss per share from continuing operations of KRW 1,380 a year ago. Basic earnings per share was KRW 930 compared to basic loss per share of KRW 1,380 a year ago. Diluted earnings per share was KRW 630.
KH Feelux Co Ltd, formerly Feelux Co Ltd, is a Korea-based company mainly engaged in the manufacture and distribution of electronic parts. The Company operates its business through five segments. The Component Business segment mainly produces and sells electronic components including transformers and line filters, among others. The Lighting Business segment mainly manufactures and sells lighting fixtures including light emitting diodes (LEDs), and others. The Material Business segment mainly produces and sells ferrite cores. The Bio Business segment mainly researches and develops immune chemotherapy, and other new drugs. The Other segment mainly engages in the construction and interior business.
KH FEELUX CO., LTD. 
